Sopharma AD
Sopharma AD, a leading pharmaceutical company headquartered in Bulgaria (BG), has been a significant player in the healthcare industry since its establishment in 1996. With a strong presence in Eastern Europe and beyond, Sopharma focuses on the development, production, and distribution of a wide range of medicinal products, including generic drugs, over-the-counter medications, and active pharmaceutical ingredients. Renowned for its commitment to quality and innovation, Sopharma AD has achieved notable milestones, including the expansion of its manufacturing capabilities and the introduction of several patented formulations. The company’s core products are distinguished by their efficacy and affordability, catering to diverse therapeutic areas. As a prominent entity in the pharmaceutical sector, Sopharma continues to enhance its market position through strategic partnerships and a robust portfolio, contributing to improved healthcare outcomes across its operational regions.
DitchCarbon Score
How does Sopharma AD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sopharma AD's score of 16 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sopharma AD's reported carbon emissions
Sopharma AD, headquartered in Bulgaria (BG), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. Consequently, there are no recorded Scope 1, 2, or 3 emissions to analyse. Additionally, the company has not established any documented reduction targets or climate pledges, which limits the available information on their climate commitments. As of now, Sopharma AD does not inherit emissions data from any parent or related organisations, and all available data is sourced directly from the company itself. Without specific emissions data or reduction initiatives, it is challenging to assess their environmental impact or commitment to climate action within the pharmaceutical industry context.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sopharma AD is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
